Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Ozanimod (Zeposia) and SIPONIMOD (MAYZENT) — clinical data, side effects, and patient experiences.
Zeposia · S1P Receptor Modulator
How it works
S1P receptor 1,5 modulator that reduces circulating lymphocytes by retaining them in lymph nodes.
Approved for
MAYZENT, Mayzent · S1P Receptor Modulator
How it works
12.1 Mechanism of Action Siponimod is an S1P receptor modulator. Siponimod binds with high affinity to S1P receptors 1 and 5. Siponimod blocks the capacity of lymphocytes to egress...
Approved for
Estimated frequency (%) based on clinical trial data
No specific warnings
No head-to-head clinical studies found for Ozanimod vs SIPONIMOD.
Both Ozanimod and SIPONIMOD belong to the S1P Receptor Modulator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.
SIPONIMOD carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.